ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.740
-0.070 (-3.87%)
At close: Sep 15, 2026, 4:00 PM EDT
1.750
+0.010 (0.57%)
After-hours: Sep 15, 2026, 7:53 PM EDT
ProKidney Market Cap
ProKidney has a market cap or net worth of $526.04 million as of September 15, 2026. Its market cap has decreased by -27.92% in one year.
Market Cap
526.04M
Enterprise Value
348.00M
1-Year Change
-27.92%
Ranking
Category
Stock Price
$1.74
ChartMarket Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $526.04M, an increase of 103.26%. That is a compound annual growth rate of 14.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 526.00M | -21.95% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
| Jun 30, 2021 | 258.80M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OmniAb | 591.74M |
| Tectonic Therapeutic | 567.91M |
| REGENXBIO | 563.09M |
| Scribe Therapeutics | 563.03M |
| Contineum Therapeutics | 557.55M |
| Prime Medicine | 556.84M |
| Eupraxia Pharmaceuticals | 555.37M |
| Arvinas | 552.51M |